Aadi Bioscience, Inc.

Ticker AADI

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

51-200 Employees
Based in Los Angeles, California

Aadi is a commercial-stage biopharmaceutical company focused on precision therapies for genetically defined cancers to bring transformational therapies to cancer patients with mTOR pathway driver alterations. Aadi received FDA approval in November 2021, and in February 2022 commenced commercialization of FYARRO® for the treatment of adult patients with locally advanced unresectable or metastatic…More

Visit website

REPORT RATINGS

4.8 / 5.0 (285)

Aadi Bioscience, Inc. reports have an aggregate usefulness score of 4.8 based on 285 reviews.

Aadi Bioscience, Inc.